These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
578 related items for PubMed ID: 17293168
1. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ. Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168 [Abstract] [Full Text] [Related]
2. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Tang WJ, Hu CP, Chen MF, Deng PY, Li YJ. Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942 [Abstract] [Full Text] [Related]
3. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW, Li YJ. Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062 [Abstract] [Full Text] [Related]
4. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Deng S, Deng PY, Jiang JL, Ye F, Yu J, Yang TL, Deng HD, Li YJ. Acta Pharmacol Sin; 2004 Dec; 25(12):1633-9. PubMed ID: 15569408 [Abstract] [Full Text] [Related]
5. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity. Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW. Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158 [Abstract] [Full Text] [Related]
6. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity. Yang TL, Chen MF, Luo BL, Xie QY, Jiang JL, Li YJ. Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325 [Abstract] [Full Text] [Related]
7. [Protective effect of losartan on injury induced by ox-LDL in endothelial cells and the relationship with asymmetric dimethylarginine]. Xie QY, Sun ZL, Chen MF, Yang TL. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):66-9. PubMed ID: 16562679 [Abstract] [Full Text] [Related]
8. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Jiang JL, Li Ns NS, Li YJ, Deng HW. Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324 [Abstract] [Full Text] [Related]
9. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q, Li YJ. Biochem Biophys Res Commun; 2006 Oct 20; 349(2):683-93. PubMed ID: 16959216 [Abstract] [Full Text] [Related]
10. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Circulation; 1999 Jun 22; 99(24):3092-5. PubMed ID: 10377069 [Abstract] [Full Text] [Related]
11. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Monsalve E, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A, Hermenegildo C. Cardiovasc Res; 2007 Jan 01; 73(1):66-72. PubMed ID: 17097077 [Abstract] [Full Text] [Related]
12. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2. Wu Y, Zhang JJ, Li TB, Liu WQ, Li LS, Luo XJ, Jiang JL, Ma QL, Yang ZC, Peng J. J Cardiovasc Pharmacol Ther; 2016 Nov 01; 21(6):536-548. PubMed ID: 26911182 [Abstract] [Full Text] [Related]
13. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Jiang DJ, Hu GY, Jiang JL, Xiang HL, Deng HW, Li YJ. Bioorg Med Chem; 2003 Nov 17; 11(23):5171-7. PubMed ID: 14604680 [Abstract] [Full Text] [Related]
14. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM. Stroke; 2008 Jan 17; 39(1):180-4. PubMed ID: 18063827 [Abstract] [Full Text] [Related]
15. [Protective effect of insulin-like growth factor-1 on vascular endothelial function in hypercholesterolemia and the underlying mechanism]. Ji S, Ma Q, Luo X, Peng J. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan 17; 38(1):36-42. PubMed ID: 23406856 [Abstract] [Full Text] [Related]
16. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2. Zhang GG, Shi RZ, Jiang DJ, Chen YR, Jia-Chen, Tang ZY, Bai YP, Xiao HB, Li YJ. Life Sci; 2008 Mar 26; 82(13-14):699-707. PubMed ID: 18289604 [Abstract] [Full Text] [Related]
17. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine. Jiang DJ, Jiang JL, Tan GS, Du YH, Xu KP, Li YJ. Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun 26; 367(6):600-6. PubMed ID: 12750878 [Abstract] [Full Text] [Related]
18. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Yin QF, Fu SH, He P, Xiong Y. Atherosclerosis; 2007 Jan 26; 190(1):53-61. PubMed ID: 16533509 [Abstract] [Full Text] [Related]
19. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, Li YJ. Vascul Pharmacol; 2006 Mar 26; 44(3):143-8. PubMed ID: 16309971 [Abstract] [Full Text] [Related]
20. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Feng M, Liu L, Guo Z, Xiong Y. Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]